GlassScriptPhysician profile
Richard Charles Osman
NPI 1346209848
$1,207.94
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $140 · 2021: $203 · 2022: $46.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $307.49 | 2019-2020 | |
| Medtronic USA, INC. | $226.68 | 2019-2020 | |
| Intersect Ent, INC. | $199.55 | 2019-2020 | |
| Ethicon INC. | $117.89 | 2021 | |
| Livanova USA, INC. | $107.91 | 2019 | |
| Boston Scientific Corporation | $85.15 | 2021 | |
| Baxter Healthcare | $46.00 | 2022 | |
| Stryker Corporation | $39.13 | 2019 | |
| Optinose US, INC. | $27.81 | 2019-2020 | |
| Genzyme Corporation | $20.65 | 2019 | |
| Kls-Martin L.P. | $17.09 | 2019 | |
| Smith+Nephew, INC. | $12.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Osman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.